Publication
Anticoagulation after typical atrial flutter ablation: systematic review and meta‐analysis
dc.contributor.author | Ferreira, Afonso Nunes | |
dc.contributor.author | Alves, Mariana | |
dc.contributor.author | Lima Da Silva, Gustavo | |
dc.contributor.author | Cortez-Dias, Nuno | |
dc.contributor.author | De Sousa, João | |
dc.contributor.author | Pinto, Fausto J. | |
dc.contributor.author | Caldeira, Daniel | |
dc.date.accessioned | 2021-09-17T16:07:23Z | |
dc.date.available | 2021-09-17T16:07:23Z | |
dc.date.issued | 2021 | |
dc.description | © 2021Wiley Periodicals LLC | pt_PT |
dc.description.abstract | Background: Cavotricuspid isthmus (CTI) ablation in typical atrial flutter (AFL) restores sinus rhythm in 95% of patients, which may lead to the discontinuation of oral anticoagulation during follow-up. Therefore, we aimed to systematically review the clinical impact of oral anticoagulation in the incidence of thromboembolic events (TE) after typical AFL ablation. Methods: We searched for controlled studies evaluating the impact of anticoagulation in the incidence of TE in patients submitted to AFL ablation in MEDLINE, CENTRAL, PsycINFO database (June/2021). The primary outcome was TE events (ischemic stroke or systemic embolism). A meta-analysis was performed deriving risk ratios (RR) and 95% confidence intervals (CI). Statistical heterogeneity was measured through I2 metric. The confidence in the evidence was appraised with Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Results: Eight observational studies with 4870 patients were included. TE events were not significantly reduced (RR 1.18, 95% CI 0.59-2.36; n = 4870; GRADE very low). A meta-regression showed that for each 10% increase in the prevalence of previous AF in the studied population, anticoagulation reduced TE risk in 32%. There were no significant differences regarding bleeding events (RR 2.16, 95% CI 0.43-10.97, I2 = 0%; GRADE low), but there was a lower all-cause mortality (RR 0.24, 95% CI 0.17-0.32, GRADE low). Conclusion: The best available evidence lacks robustness and the data did not definitely associate anticoagulation after typical AFL ablation with reduced TE. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Pacing Clin Electrophysiol. 2021 Aug 18 | pt_PT |
dc.identifier.doi | 10.1111/pace.14342 | pt_PT |
dc.identifier.eissn | 1540-8159 | |
dc.identifier.issn | 0147-8389 | |
dc.identifier.uri | http://hdl.handle.net/10451/49543 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | John Wiley & Sons, Inc. | pt_PT |
dc.relation.publisherversion | https://onlinelibrary.wiley.com/journal/15408159 | pt_PT |
dc.subject | Cavotricuspid isthmus ablation | pt_PT |
dc.subject | Oral anticoagulation | pt_PT |
dc.subject | Thromboembolic events | pt_PT |
dc.subject | Typical atrial flutter | pt_PT |
dc.title | Anticoagulation after typical atrial flutter ablation: systematic review and meta‐analysis | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.title | Pacing and Clinical Electrophysiology | pt_PT |
person.familyName | Nunes-Ferreira | |
person.familyName | Alves | |
person.familyName | Lima da Silva | |
person.familyName | Cortez-Dias | |
person.familyName | de Sousa | |
person.familyName | Pinto | |
person.familyName | Caldeira | |
person.givenName | Afonso | |
person.givenName | Mariana | |
person.givenName | Gustavo | |
person.givenName | Nuno | |
person.givenName | João | |
person.givenName | Fausto J. | |
person.givenName | Daniel | |
person.identifier | 1153684 | |
person.identifier | 1308889 | |
person.identifier.ciencia-id | 0419-C014-BA22 | |
person.identifier.ciencia-id | 0718-09A9-D4EA | |
person.identifier.ciencia-id | FB15-EB01-5F40 | |
person.identifier.ciencia-id | D612-D3C3-6E1D | |
person.identifier.ciencia-id | 7D1D-FC15-13D6 | |
person.identifier.ciencia-id | C311-AEDD-6DBB | |
person.identifier.ciencia-id | AA19-EC35-8D01 | |
person.identifier.orcid | 0000-0002-2836-9497 | |
person.identifier.orcid | 0000-0002-1369-8423 | |
person.identifier.orcid | 0000-0003-3138-8354 | |
person.identifier.orcid | 0000-0002-9244-4631 | |
person.identifier.orcid | 0000-0003-2782-8214 | |
person.identifier.orcid | 0000-0002-8034-4529 | |
person.identifier.orcid | 0000-0002-2520-5673 | |
person.identifier.rid | O-3034-2016 | |
person.identifier.rid | G-9363-2015 | |
person.identifier.scopus-author-id | 56591535500 | |
person.identifier.scopus-author-id | 7102740158 | |
person.identifier.scopus-author-id | 36623384200 | |
rcaap.rights | restrictedAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | ea30d6c6-61a5-4dc8-a175-d4b3631c168a | |
relation.isAuthorOfPublication | 6fd2983b-8b7d-452d-b03b-999007533ee0 | |
relation.isAuthorOfPublication | 19eb513b-6abf-4171-905e-8d8c36a33c6c | |
relation.isAuthorOfPublication | 36f4a32d-38e4-4c28-9140-4ba468059a22 | |
relation.isAuthorOfPublication | ea6febb2-da5d-4296-a20a-3adac1f59117 | |
relation.isAuthorOfPublication | 5f44176f-69f5-482c-83cd-ab94425a6ec3 | |
relation.isAuthorOfPublication | eba36bb8-5eb3-4ccc-88f8-bd7012d42382 | |
relation.isAuthorOfPublication.latestForDiscovery | ea6febb2-da5d-4296-a20a-3adac1f59117 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Anticoagulation_typical.pdf
- Size:
- 775.06 KB
- Format:
- Adobe Portable Document Format